CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 159 filers reported holding CASTLE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $483,459 | -3.5% | 21,279 | 0.0% | 0.18% | -8.4% |
| Q4 2022 | $500,908 | -9.7% | 21,279 | 0.0% | 0.20% | -25.5% |
| Q3 2022 | $555,000 | +18.8% | 21,279 | 0.0% | 0.27% | +25.5% |
| Q2 2022 | $467,000 | -51.1% | 21,279 | 0.0% | 0.22% | -43.3% |
| Q1 2022 | $955,000 | +4.7% | 21,279 | 0.0% | 0.38% | +12.7% |
| Q4 2021 | $912,000 | -35.5% | 21,279 | 0.0% | 0.34% | -39.2% |
| Q3 2021 | $1,415,000 | -9.3% | 21,279 | 0.0% | 0.56% | -5.6% |
| Q2 2021 | $1,560,000 | +7.1% | 21,279 | 0.0% | 0.59% | +1.6% |
| Q1 2021 | $1,457,000 | -29.1% | 21,279 | -30.5% | 0.58% | -33.3% |
| Q4 2020 | $2,055,000 | +30.5% | 30,608 | 0.0% | 0.87% | +14.2% |
| Q3 2020 | $1,575,000 | -19.8% | 30,608 | -41.3% | 0.76% | -16.4% |
| Q2 2020 | $1,964,000 | +19.0% | 52,112 | -5.8% | 0.91% | +3.5% |
| Q1 2020 | $1,650,000 | – | 55,344 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |